Quality of Life in Chinese Working and School Age Population With MDD

NCT04986124 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-08-02

No results posted yet for this study

Summary

Major depressive disorder (MDD) is a common mental illness with high prevalence and global burden. Previous studies revealed that over 70% patients in remission still had decreased quality of life, severe function impairment, low positive mental health score and poor coping ability. However, few studies focus on working and school age patients with MDD. A GBD survey showed that over 40% MDD patients are 15-50 years old. Therefore, we initiate the present multi-center cross-sectional survey to investigate the associations between clinical symptoms, cognitive function, occupational/study ability, and quality of life in Chinese working and school age population with MDD who are in remission.

Conditions

Interventions

OTHER

treatment as usual

No inervention. Treatment regime remains unchanged.

Sponsors & Collaborators

  • Beijing HuiLongGuan Hospital

    collaborator OTHER
  • Huaxi Hospital

    collaborator OTHER
  • Second Xiangya Hospital of Central South University

    collaborator OTHER
  • Nanjing Brain Hospital, Nanjing Medical University

    collaborator UNKNOWN
  • Guangzhou Psychiatric Hospital

    collaborator OTHER_GOV
  • First Affiliated Hospital Xi'an Jiaotong University

    collaborator OTHER
  • Shanghai Mental Health Center

    lead OTHER

Principal Investigators

  • Jun Chen, M.D., Ph.D · Shanghai Mental Health Center (SMHC)

Eligibility

Min Age
16 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2021-08-30
Completion
2021-08-30

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04986124 on ClinicalTrials.gov